TY  - GEN
AU  - Shridhar,V
AU  - Bible,K C
AU  - Staub,J
AU  - Avula,R
AU  - Lee,Y K
AU  - Kalli,K
AU  - Huang,H
AU  - Hartmann,L C
AU  - Kaufmann,S H
AU  - Smith,D I
TI  - Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer
SN  - 0008-5472
PY  - 2001///0614
KW  - Amino Acid Sequence
KW  - Azacitidine
KW  - analogs & derivatives
KW  - Base Sequence
KW  - Chromosome Mapping
KW  - Cisplatin
KW  - pharmacology
KW  - Cloning, Molecular
KW  - DNA, Neoplasm
KW  - genetics
KW  - Decitabine
KW  - Down-Regulation
KW  - Drug Resistance, Multiple
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - Gene Silencing
KW  - HSP40 Heat-Shock Proteins
KW  - Heat-Shock Proteins
KW  - biosynthesis
KW  - Humans
KW  - In Situ Hybridization, Fluorescence
KW  - Loss of Heterozygosity
KW  - Molecular Sequence Data
KW  - Ovarian Neoplasms
KW  - drug therapy
KW  - Oximes
KW  - Paclitaxel
KW  - Piperazines
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Sequence Homology, Amino Acid
KW  - Topotecan
KW  - Transfection
KW  - Tumor Cells, Cultured
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S
ER  -